AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS

作者:Handelsman Yehuda; Henry Robert R; Bloomgarden Zachary T; Dagogo Jack Sam; DeFronzo Ralph A; Einhorn Daniel; Ferrannini Ele; Fonseca Vivian A; Garber Alan J; Grunberger George; LeRoith Derek; Umpierrez Guillermo E; Weir Matthew R
来源:Endocrine Practice, 2016, 22(6): 753-762.
DOI:10.4158/EP161292.PS

摘要

This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position and consensus statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

  • 出版日期2016-6